Welcome to
Adcock Ingram
Our website offers information about our Company that will give you an understanding of who we are and what we do and how we are building a world class, leading, branded healthcare company. Please contact us should you require any further information on our products or services
to contact us click here
  • COVID-19
  • Citro-soda
  • Citro-soda
  • Corenza
  • Dllinct
  • Epi-Max
  • Immuenza
  • Dllinct
  • Dllinct
  • Vita-thion
  • Hopetober
  • Adcock Ingram, a level one B-BBEE pharmaceutical company

  • A leading world-class branded healthcare company

  • Our commitment to quality drives our world-class manufacturing facilities

  • Adding value to life through our Corporate Social Investment programmes

  • Producing pharmaceutical products in the most environmentally friendly way

Latest News

Current News

Contact Medical Affairs or report an Adverse Event

To contact medical affairs or to report an adverse event
click here

News and Media

For the latest Adcock Ingram news
click here


For careers that add value to people’s lives
click here

Group Results

Group Audited Results Booklet 30 June 2020
click here


For more information on our products
click here

Financial Indicators

Latest Share Price
4220 cents
Percentage Change: 4.20
Code: AIP
PE Ratio: 10.11
EY: 9.89
DY: 2.37
ZAR/USD: 16.2537
Interim Dividend (cents): 100.00
Final Dividend (cents): N/A
30 day vwap
4163 cents